We are live on ! Find out more
INVA icon

Innoviva

212 hedge funds and large institutions have $1.2B invested in Innoviva in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 79 increasing their positions, 77 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more call options, than puts

Call options by funds: $477K | Put options by funds: $152K

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

15% more capital inflows, than outflows

Capital inflows: $68.4M | Capital outflows: $59.5M

3% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 77

0.38% more ownership

Funds ownership: 111.55% → 111.93% (+0.38%)

1% less funds holding

Funds holding: 214 → 212 (-2)

4% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 23

Holders
212
Holders Change
-2
Holders Change %
-0.93%
% of All Funds
3.05%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
22
Increased
79
Reduced
77
Closed
23
Calls
$477​K
Puts
$152​K
Net Calls
+$325​K
Net Calls Change
-⁠$134​K

INVA Hedge Fund Activity: Q2 2024 in Review

212 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q2 2024, worth a combined $1.2B — up 8% from $1.11B a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of INVA and 22 opened new positions — a net loss of 1 holder — while 77 trimmed existing stakes and 79 added.

The largest buyer was Westfield Capital Management, adding an estimated $8.81M. The largest seller was BlackRock, cutting an estimated $7.96M.

  • 212 institutional investors held Innoviva (INVA) as of Q2 2024, down from 214 in Q1 2024.
  • Funds reported $1.2B of Innoviva stock for Q2 2024, up 8% quarter-over-quarter.
  • 22 funds opened new Innoviva positions in Q2 2024 and 23 closed out, a net change of -1 holder.
  • The largest Innoviva buyer in Q2 2024 was Westfield Capital Management, an estimated $8.81M added.
  • The largest Innoviva seller in Q2 2024 was BlackRock, an estimated $7.96M sold.

Based on aggregated 13F filings for Q2 2024.